Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer
- PMID: 28261632
- PMCID: PMC5336315
- DOI: 10.14440/bladder.2016.89
Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer
Abstract
The effect of radical cystectomy and extended pelvic lymph node dissection (RC/PLND) on the survival of patients with locally advanced and/or regionally metastatic bladder cancer is unknown. However, emerging evidence suggests that there may be survival benefit to a subset of select patients with this disease who demonstrate a response to chemotherapy. This article will review the current literature on the role of RC/PLND in the consolidative treatment of locally advanced and regionally metastatic bladder cancer.
Keywords: bladder cancer; consolidative surgery; cystectomy; metastatic.
Conflict of interest statement
Competing interests: The authors have declared that no competing interests exist.
Similar articles
-
Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review.Bladder Cancer. 2018 Jan 20;4(1):31-40. doi: 10.3233/BLC-170130. Bladder Cancer. 2018. PMID: 29430505 Free PMC article.
-
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.Eur Urol Focus. 2021 Sep;7(5):1067-1074. doi: 10.1016/j.euf.2020.09.009. Epub 2020 Oct 2. Eur Urol Focus. 2021. PMID: 33020030 Clinical Trial.
-
Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients.BJU Int. 2019 Aug;124(2):242-250. doi: 10.1111/bju.14736. Epub 2019 Apr 3. BJU Int. 2019. PMID: 30811784
-
Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.Cochrane Database Syst Rev. 2019 May 14;5(5):CD013336. doi: 10.1002/14651858.CD013336. Cochrane Database Syst Rev. 2019. PMID: 31111956 Free PMC article.
-
Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer.Nat Rev Urol. 2018 Nov;15(11):686-692. doi: 10.1038/s41585-018-0066-1. Nat Rev Urol. 2018. PMID: 30104615 Review.
Cited by
-
Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladder.Transl Androl Urol. 2017 Dec;6(6):1117-1122. doi: 10.21037/tau.2017.08.09. Transl Androl Urol. 2017. PMID: 29354498 Free PMC article.
-
2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer.Can Urol Assoc J. 2025 Jan;19(1):E1-E16. doi: 10.5489/cuaj.9096. Can Urol Assoc J. 2025. PMID: 39899885 Free PMC article. No abstract available.
-
Systemic induction therapy in patients with locally advanced or node-positive urothelial carcinoma: Evaluating treatment outcomes.Bladder Cancer. 2024 Dec 20;10(4):251-263. doi: 10.1177/23523735241301646. eCollection 2024 Dec. Bladder Cancer. 2024. PMID: 40035081 Free PMC article. Review.
References
-
- American Cancer Society. Cancer Facts and Figures. 2015.
-
- Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675. - PubMed
-
- Bellmunt J, Von_Der_Maase H, Mead GM, Skoneczna I, De_Santis M, et al. Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987. J Clin Oncol. 2012;30:1107–13. doi: 10.1200/JCO.2011.38.6979. - DOI - PMC - PubMed
-
- Dalbagni G, Genega E, Hashibe M, Zhang ZF, Russo P, et al. Cystectomy for bladder cancer: a contemporary series. J Urol. 2001;165:1111–1116. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources